Stockscreener 앱 받기
81.47
0.54%
-0.44
시간 외 거래:
81.47
Henry Schein Inc 주식(HSIC)의 최신 뉴스
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Henry Schein (HSIC) - The Globe and Mail
Henry Schein (HSIC): UBS Maintains "Neutral" Rating, Price Targe - GuruFocus
Henry Schein Reports Strong Q4 Earnings Exceeding Expectations - Intellectia AI
These Analysts Increase Their Forecasts On Henry Schein After Upbeat Q4 Results - Benzinga
Research Alert: CFRA Maintains Sell Rating On Shares Of Henry Schein Inc. - 富途牛牛
Barrington Adjusts Price Target on Henry Schein to $97 From $79, Maintains Outperform Rating - marketscreener.com
UBS Adjusts Price Target on Henry Schein to $87 From $79, Maintains Neutral Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Henry Schein to $100 From $90 - marketscreener.com
Baird Adjusts Price Target on Henry Schein to $104 From $100 - marketscreener.com
Leerink Partners Adjusts Price Target on Henry Schein to $87 From $75 - marketscreener.com
Henry Schein, Inc. (NASDAQ:HSIC) Q4 2025 Earnings Call Transcript - Insider Monkey
Stifel Adjusts Price Target on Henry Schein to $84 From $72 - marketscreener.com
Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC), Delcath Systems (DCTH) and Certara (CERT) - The Globe and Mail
Decoding Henry Schein Inc (HSIC): A Strategic SWOT Insight - GuruFocus
Henry Schein Balances Strong Growth With Margin Pressure - TipRanks
Henry Schein (HSIC) Margin Stays Near 3% And Tests Premium P/E Narrative - simplywall.st
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Analyst Expectations For Henry Schein's Future - Benzinga
Henry Schein stock hits 52-week high at 83.92 USD By Investing.com - Investing.com South Africa
Henry Schein (HSIC) Stock Trades Up, Here Is Why - Finviz
Henry Schein Q4 2025 slides: strongest sales growth in 15 quarters - Investing.com Canada
Henry Schein Reports Growth in Dental and Specialty Product Sales for 2025 - Orthodontic Products
Piper Sandler Raises Henry Schein Price Target to $99 From $83 - marketscreener.com
Leerink Partners Raises Henry Schein Price Target to $87 From $75 - marketscreener.com
Henry Schein Inc (HSIC) Q4 2025 Earnings Call Highlights: Record Sales Growth and Strategic Advancements - GuruFocus
Henry Schein Stock Hits 52-Week HighHere's WhyHenry Schein (NASDAQ:HSIC) - Benzinga
Henry Schein (HSIC) Q4 2025 Earnings Transcript - The Globe and Mail
Henry Schein Stock Has Traded Flat Over 12 Months: Here’s Where the Stock Could Go in 2026 - TIKR.com
Henry Schein Q4 2025 Earnings: Revenue Up, Profit Below EstimatesNews and Statistics - IndexBox
Henry Schein beats quarterly profit estimates on stable dental market - marketscreener.com
Henry Schein, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Henry Schein Reports Fourth Quarter and Full Year 2025 Financial Results and Introduces 2026 Financial Guidance - Zenopa
Henry Schein Q4 Earnings Call Highlights - Yahoo Finance
Henry Schein beats expectations as dental equipment rebounds - marketscreener.com
Henry Schein stock hits 52-week high at 83.92 USD - Investing.com
Henry Schein's (NASDAQ:HSIC) Q4 CY2025 Sales Beat Estimates - Finviz
Henry Schein, Vir Biotechnology, Ultra Clean Holdings And Other Big Stocks Moving Higher On Tuesday - Benzinga
Earnings call transcript: Henry Schein’s Q4 2025 earnings surpass forecasts, stock rises - Investing.com
Henry Schein (HSIC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018. - marketscreener.com
Robert W. Baird upgrades Henry Schein (HSIC) to a Buy - The Globe and Mail
Henry Schein beats quarterly profit estimates on strong dental, medical equipment sales - marketscreener.com
HSIC Q4 Earnings & Revenues Beat Estimates, Margins Down - TradingView
Henry Schein, Inc. Reports Earnings Results for the Fourth Quarter Ended December 27, 2025 - marketscreener.com
Henry Schein’s (NASDAQ:HSIC) Q4 CY2025 Sales Beat Estimates - Yahoo Finance
Henry Schein (HSIC) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
Henry Schein (HSIC) Reports Strong Q4 Revenue with Growth Across All Sectors - GuruFocus
Henry Schein Q4 2025 results: $3.4B sales & EPS growth - grafa.com
Henry Schein beats estimates on earnings and revenue By Investing.com - Investing.com India
Henry Schein beats estimates on earnings and revenue - Investing.com South Africa
Henry Schein: Fourth Quarter Earnings Overview - Bitget
(HSIC) Henry Schein Expects Fiscal 2026 Non-GAAP EPS Range $5.23$5.37, vs. FactSet Est of $5.29 - marketscreener.com
Henry Schein earnings beat by $0.04, revenue topped estimates - Investing.com South Africa
Henry Schein Inc. Q4 Profit Advances - Nasdaq
Earnings Flash (HSIC) Henry Schein, Inc. Reports Q4 Revenue $3.44B, vs. FactSet Est of $3.35B - marketscreener.com
Henry Schein (HSIC) Valuation Check As Earnings Loom And Analyst Upgrade Draws Fresh Attention - simplywall.st
Henry Schein Shares Rise After Baird Upgrade - marketscreener.com
Henry Schein, Inc. (HSIC): Analysts Rate Stock as Outperform With Significant Upside Potential - 富途牛牛
Henry Schein earnings on deck: Can dental recovery take hold? By Investing.com - Investing.com South Africa
Henry Schein earnings on deck: Can dental recovery take hold? - Investing.com Nigeria
Earnings Preview: Henry Schein - Benzinga
This Henry Schein Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday - Benzinga
Baird upgrades Henry Schein stock rating on dental market recovery By Investing.com - Investing.com South Africa
9.37%
6.92%
자본화:
|
볼륨(24시간):